Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about LLY

Recent news which mentions LLY

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
32 33 Next >
Eli Lilly's Investigational Cancer Drug Cuts Risk Of Death By 38% In Breast Cancer Patients
Tickers LLY NEWS
Tags Briefs Biotech Stories That Matter
From Benzinga
Eli Lilly Unusual Options Activity
Tickers LLY
Tags Benzinga LLY BZI/UOA
From Benzinga
Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts
Tickers LLY
Tags KeyProj pharmaceuticals Stories That Matter
From Benzinga
What's Going On With Eli Lilly Stock On Tuesday?
Tickers LLY NEWS
Tags News General Large Cap
From Benzinga
As Eli Lilly Shares Gain Over 35% YTD, Drugmaker Announces $15B Share Buyback Program And Boosts Dividend By 15%
Tickers LLY NEWS
Tags General News Pooja Rajkumari
From Benzinga
Warning: This Skyrocketing Stock Has a Hidden Risk
Tickers LLY NVO VKTX
Tags NVO Market News Recent Press Releases
From Motley Fool
Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown
Tickers BIIB LLY NEWS
Tags BIIB Benzinga Analyst Ratings
From Benzinga
Just Two Months After IPO, BioAge Labs Stops Eli Lilly-Collaborated Obesity Trial On Safety Concerns
Tickers BIOA LLY NEWS
Tags Market News Equities Movers
From Benzinga
Eli Lilly Stock Just Got Even Sweeter. Here's Why It's Worth Buying Now
Tickers LLY NVO
Tags Market News NVO LLY
From Motley Fool
3 No-Brainer Growth Stocks to Buy in December
Tickers LLY NVO VRTX
Tags LLY Recent Press Releases VRTX
From Motley Fool
Could Eli Lilly Beat Rivals in the Billion-Dollar Weight Loss Drug Market in 2025? Evidence Is Piling Up, and Here's What It Says.
Tickers LLY NVO
Tags NVO Market News LLY
From Motley Fool
Eli Lilly Investments In Production Reach $23 Billion With Additional $3 Billion Expansion At US Facility
Tickers LLY NEWS
Tags Benzinga Health Care LLY
From Benzinga
Billionaire Izzy Englander Is Buying This Obesity Drug Stock That Could Soar Nearly 20%, According to Wall Street
Tickers LLY
Tags Market News LLY Recent Press Releases
From Motley Fool
How Much Did Americans Overspend On Weight Loss Medications in 2024? GoodRx Reveals
Tickers GDRX LLY NEWS NVO
Tags Top Stories Benzinga General
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers AMGN DHR ELV HIMS
Tags Market News DHR Options
From Benzinga
This Healthcare Stock Is a Favorite of Billionaires. But Is It a Buy?
Tickers AMGN LLY MRK NVO
Tags LLY UNH PFE
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Tickers HIMS LLY NVO PACB
Tags SAVA PFE LLY
From Benzinga
Stock Of The Day: Where Will The Eli Lilly Rally End?
Tickers LLY NVO
Tags Stock of the Day LLY Benzinga
From Benzinga
Decoding Eli Lilly's Options Activity: What's the Big Picture?
Tickers LLY
Tags Options Markets Market News
From Benzinga
Eli Lilly's Zepbound Vs. Novo Nordisk's Wegovy - Which Shows Greater Weight Loss?
Tickers LLY NEWS NVO
Tags Biotech Stories That Matter General
From Benzinga
Jim Cramer: This Energy Stock Is A 'Winner,' But Navitas Semiconductor Is 'Losing A Lot Of Money'
Tickers LB LLY NEWS NVTS
Tags Stories That Matter Benzinga Media
From Benzinga
Eli Lilly Just Got a Bundle of Good News: Time to Buy?
Tickers AMGN LLY NVO
Tags Recent Press Releases LLY AMGN
From Motley Fool
Weight Loss Drug Wars Heat Up: Amgen Challenges Eli Lilly, Novo's Dominance
Tickers AMGN LLY MRK NVO
Tags AMGN wegovy obesity
From Benzinga
Want To Bet On Ozempic, Wegovy Success? Defiance Introduces Leveraged ETF To Capture Novo Nordisk Momentum
Tickers LLY LLYX NEWS NVO
Tags Biotech Stories That Matter ETFs
From Benzinga
Macy's Multimillion-Dollar Error
Tickers AMZN CAG HD IMAX
Tags NFLX MSTR Recent Press Releases
From Motley Fool
Big Pharma Pushes To Revise Biden-era Medicare Drug Price Negotiation Law Under Trump
Tickers LLY NEWS NVO
Tags NVO Market News Briefs
From Benzinga
Weight Loss Drugs Like Wegovy, Zepbound Linked To Reduced Alcohol Use: Study
Tickers LLY NEWS NVO
Tags Stories That Matter Biotech General
From Benzinga
Prediction: This Unstoppable Vanguard ETF Will Beat the S&P 500 Again in 2025
Tickers AAPL AMZN AVGO COST
Tags GOOGL MCD TSLA
From Motley Fool
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
Tickers AMGN LLY NVO
Tags AMGN LLY Recent Press Releases
From Motley Fool
Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program
Tickers BMY JNJ LLY NEWS
Tags LLY Legal Health Care
From Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.